Reed Elizabeth E

Chief Legal Officer and GCTravere Therapeutics, Inc. (TVTX) · full profile →Form 4 · filed Apr 15, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$2.1M
Net Open-Market Flow
-$2.1M
Transactions
11
8 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 15, 2026Sell(S)2K$42.53$66K105K
Apr 15, 2026Sell(S)5K$41.62$218K107K
Apr 14, 2026Option exercise(M)20K$17.96$359K149K
Apr 14, 2026Sell(S)38K$41.07$1.5M119K
Apr 14, 2026Sell(S)7K$41.93$303K112K
Apr 14, 2026Option exercise(M)8K$15.46$116K157K
Apr 14, 2026Option exercise(M)10K$19.08$191K129K
Apr 13, 2026Grant(A)14K$0119K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 14, 2026Option exercise(M)8K$038K
Apr 14, 2026Option exercise(M)10K$00
Apr 14, 2026Option exercise(M)20K$020K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001283303-26-000008) within minutes of acceptance. Every field above traces to the original document. Verify it directly: